Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. CWAN
CWAN logo

CWAN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Clearwater Analytics Holdings Inc (CWAN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
23.180
1 Day change
-0.90%
52 Week Range
28.180
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Clearwater Analytics Holdings Inc (CWAN) is not a good buy for a beginner, long-term investor at this time. The stock is in the process of being acquired at $24.55 per share, which limits upside potential. Furthermore, the company's financial performance shows declining profitability, and there are no strong trading signals or positive catalysts to justify an investment.

Technical Analysis

The MACD is positive and expanding, indicating a bullish trend. The RSI is neutral at 59.355, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock is trading near its resistance levels (R1: 23.616, R2: 23.781), suggesting limited upward movement.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
8
Buy
2

Positive Catalysts

  • Hedge funds are significantly increasing their positions, with a 495.69% increase in buying over the last quarter.

Neutral/Negative Catalysts

  • The company is being acquired for $24.55 per share, capping the stock's upside potential. Multiple law firms are investigating the fairness of the buyout price, creating uncertainty. Analysts have downgraded the stock following the acquisition announcement.

Financial Performance

In Q4 2025, revenue increased by 71.95% YoY to $217.46M. However, net income dropped to -$12.066M (-102.88% YoY), EPS fell to -$0.04 (-103.20% YoY), and gross margin declined to 67.24% (-8.47% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

UBS and Wells Fargo downgraded the stock to Neutral/Equal Weight with a price target of $24.55, citing the acquisition agreement. Analysts view deal completion as highly likely, limiting further price appreciation.

Wall Street analysts forecast CWAN stock price to rise
10 Analyst Rating
Wall Street analysts forecast CWAN stock price to rise
5 Buy
5 Hold
0 Sell
Moderate Buy
Current: 23.390
sliders
Low
24.55
Averages
27.83
High
36
Current: 23.390
sliders
Low
24.55
Averages
27.83
High
36
UBS
Buy -> Neutral
downgrade
$30
AI Analysis
2026-01-26
Reason
UBS
Price Target
$30
AI Analysis
2026-01-26
downgrade
Buy -> Neutral
Reason
UBS downgraded Clearwater Analytics to Neutral from Buy with a price target of $24.55, down from $30, after the company reached an agreement to be acquired by an investor group led by Permira and Warburg Pincus for $24.55 per share in cash.
Wells Fargo
Michael Turrin
Overweight -> Equal Weight
downgrade
$27
2026-01-08
Reason
Wells Fargo
Michael Turrin
Price Target
$27
2026-01-08
downgrade
Overweight -> Equal Weight
Reason
Wells Fargo analyst Michael Turrin downgraded Clearwater Analytics to Equal Weight from Overweight with a price target of $24.55, down from $27, following the company's agreement to be taken private at $24.55 per share by a Premira and Warburg Pincus led investor group. Wells views deal completion as highly likely.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CWAN
Unlock Now

People Also Watch